The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The Drug Formulation Market Between 2026 And 2030?
The drug formulation market size has seen substantial growth over recent years. It is forecast to increase from $2045.31 billion in 2025 to $2221.54 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.6%. This historical expansion can be linked to factors such as growth in generic drug demand, rising prevalence of chronic diseases, advancements in pharmaceutical research, expansion of hospital and clinic networks, and increasing investments in R&D.
The drug formulation market size is projected to experience robust expansion over the coming years. This market is predicted to reach $3196.24 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This anticipated growth during the forecast period can be attributed to several factors, including the rise of gene and cell therapies, the integration of AI in drug design, the advancement of novel excipients, a surge in biologics and specialty drugs, and the broadening of nascent pharmaceutical markets. Key trends anticipated within the forecast timeframe encompass personalized drug formulations, sophisticated drug delivery systems, the ongoing development of biologics and biosimilars, enhancements in formulation stability and shelf-life, and a continued focus on regulatory compliance and quality assurance.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9900&type=smp
Which Primary Drivers Are Impacting The Drug Formulation Market Growth?
The drug formulation market is projected to grow as personalized medicine sees increasing adoption. This innovative healthcare method customizes medical treatments and interventions to align with the unique characteristics of each patient, specifically tailoring therapies based on individual factors such as genetics and biomarkers. This approach necessitates the development of bespoke drug formulations to optimize both efficacy and safety for every patient. The ramifications include a demand for individualized treatment plans, formulations that accommodate genomic insights, enhanced drug responses, and specialized therapies for rare diseases. For example, in 2023, the Personalized Medicine Coalition (PMC), a US-based non-profit, reported that personalized medicines constituted approximately 38 percent of all newly approved therapeutic molecular entities, an increase from 34 percent in 2022. Therefore, the expanding adoption of personalized medicine is a key driver for the growth of the drug formulation market.
Which Segment Categories Are Included In The Drug Formulation Market Segment Analysis?
The drug formulation market covered in this report is segmented –
1) By Dosage Form: Oral formulations, Parenteral Formulations, Topical Formulations, Inhalation Formulations
2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations
3) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases
4) By End-User: Big Pharma, Small And Medium Pharma, Biotech Companies
Subsegments:
1) By Oral Formulations: Tablets, Capsules, Powders, Liquids Or Solutions
2) By Parenteral Formulations: Injectables, Implants, Infusions
3) By Topical Formulations: Creams, Ointments, Gels, Transdermal Patches
4) By Inhalation Formulations: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
Which Trends Are Influencing Demand In The Drug Formulation Market?
Leading companies in the drug formulation sector are developing new fixed dose combination drugs to achieve a competitive advantage in the type 2 diabetes market. A Fixed Dose Combination (FDC) is defined as a pharmaceutical preparation containing two or more active ingredients combined at a fixed ratio of doses within a single dosage form. For example, in October 2023, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company, launched its first triple-drug fixed-dose combination under the brand name Zita DM. This product comprises the DPP4 inhibitor, Teneligliptin (20mg), the SGLT2 inhibitor, Dapagliflozin (10mg), and Metformin SR (500mg/1000mg) in a fixed dose. It is prescribed for once-daily administration to improve glycemic control in patients with Type 2 diabetes.
Who Are The Active Companies Shaping The Drug Formulation Market?
Major companies operating in the drug formulation market are AstraZeneca PLC, The Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., C.H. Boehringer Sohn AG & Co. KG, F. Hoffmann-La Roche AG, Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., GlaxoSmithKline plc, Novo Nordisk A/S, Amgen Inc., Viatris Inc., Sandoz International GmbH, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Torrent Pharmaceuticals Limited, Jubilant Life Sciences Limited, Cadila Healthcare Limited, Glenmark Pharmaceuticals Ltd., Wockhardt Ltd., Hikma Pharmaceuticals plc
Get The Full Drug Formulation Market Report:
https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report
Where Is The Drug Formulation Market Primarily Concentrated By Region?
North America was the largest region in the drug formulation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug formulation market report during the forecast period. The regions covered in the drug formulation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Drug Formulation Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report
Browse Through More Reports Similar to the Global Drug Formulation Market 2026, By The Business Research Company
Drug Formulation Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report
Oral Solid Dosage Pharmaceutical Formulation Market Report 2026
Active Pharmaceutical Ingredients Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model